CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2104
-0.0196 (-8.52%)
Sep 28, 2026, 3:02 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $310.93 million as of September 28, 2026. Its market cap has decreased by -10.01% in one year.
Market Cap
310.93M
Enterprise Value
326.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.21
ChartMarket Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 310.93M, an increase of 5,514.97%. That is a compound annual growth rate of 21.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 325.98M | -8.34% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 673.14M |
| Northwest Biotherapeutics | 272.90M |
| Glorywin Entertainment Group | 234.77M |
| BetterLife Pharma | 148.32M |
| Vaxart | 110.62M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 76.02M |
| Nuo Therapeutics | 60.54M |